Frontiers in pediatrics · 2026
The association between Children's sleep quality and juvenile idiopathic arthritis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Li Linxia, Di Yazhen, Liu Zhanli, Hao Zelin
Аннотация
OBJECTIVE: To investigate possible sleep disturbances in children with juvenile idiopathic arthritis (JIA).
METHODS: This case-control investigation evaluated 48 JIA patients vs. 90 healthy controls through comprehensive clinical assessments. Disease activity was quantified using the Juvenile Arthritis Disease Activity Score (JADAS-27), while health-related quality of life was measured with the Child Health Questionnaire (CHQ-PF28). Pain intensity was assessed through dual Methods: Visual Analog Scale (VAS) and Wong Baker Faces Scale. Fatigue levels were evaluated via the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale (PedsQL-MFS), and sleep quality was analyzed using both the Children's Sleep Habits Questionnaire (CSHQ) and Sleep Disturbance Scale for Children (SDSC). All statistical analyses were conducted in SPSS 26.0, employing independent t-tests for intergroup comparisons and Spearman correlation analysis for variable relationships.
RESULTS: The incidence of sleep disturbance was significantly higher in the JIA group (P < 0.01). CSHQ assessments reveal abnormal total scores and six subdomains (sleep duration, daytime sleepiness, etc.; all P < 0.05), with specific correlations: total scores link to disease activity (JADAS-27/AJC; P = 0.021-0.05), shortened sleep duration strongly associates with ESR/functional status (P = 0.002/0.006), and daytime sleepiness connects to physician global assessments (PGA/PGE; P = 0.017-0.029). SDSC evaluations indicate abnormalities in four domains (all P < 0.05), notably: night hyperhidrosis correlates with disease activity markers (P = 0.032-0.039), excessive sleepiness associates with fatigue/functional impairment (P = 0.014/0.038), and arousal disorders relate to medication use (P = 0.029).
CONCLUSIONS: JIA patients show significantly higher rates of sleep disorders compared to healthy children, primarily due to disease activity, functional impairment, and medication effects.
METHODS: This case-control investigation evaluated 48 JIA patients vs. 90 healthy controls through comprehensive clinical assessments. Disease activity was quantified using the Juvenile Arthritis Disease Activity Score (JADAS-27), while health-related quality of life was measured with the Child Health Questionnaire (CHQ-PF28). Pain intensity was assessed through dual Methods: Visual Analog Scale (VAS) and Wong Baker Faces Scale. Fatigue levels were evaluated via the Pediatric Quality of Life Inventory Multidimensional Fatigue Scale (PedsQL-MFS), and sleep quality was analyzed using both the Children's Sleep Habits Questionnaire (CSHQ) and Sleep Disturbance Scale for Children (SDSC). All statistical analyses were conducted in SPSS 26.0, employing independent t-tests for intergroup comparisons and Spearman correlation analysis for variable relationships.
RESULTS: The incidence of sleep disturbance was significantly higher in the JIA group (P < 0.01). CSHQ assessments reveal abnormal total scores and six subdomains (sleep duration, daytime sleepiness, etc.; all P < 0.05), with specific correlations: total scores link to disease activity (JADAS-27/AJC; P = 0.021-0.05), shortened sleep duration strongly associates with ESR/functional status (P = 0.002/0.006), and daytime sleepiness connects to physician global assessments (PGA/PGE; P = 0.017-0.029). SDSC evaluations indicate abnormalities in four domains (all P < 0.05), notably: night hyperhidrosis correlates with disease activity markers (P = 0.032-0.039), excessive sleepiness associates with fatigue/functional impairment (P = 0.014/0.038), and arousal disorders relate to medication use (P = 0.029).
CONCLUSIONS: JIA patients show significantly higher rates of sleep disorders compared to healthy children, primarily due to disease activity, functional impairment, and medication effects.